IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial

Nikita Kohli, Michael Lerner, Jamie Rashty, Diana Kirke, Thomas Stewart, Andrew Blitzer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences